JUNIORSTAR BY SANOFI

A half unit reusable insulin pen for young users

In 2010, around 215,000 people younger than 20 years had diabetes (type 1 or type 2) in the United States (NDIC). With such a consequent market, Sanofi’s JuniorSTAR was meant to receive a warm welcome.

The device, EU approved, responds to the needs of patients with Type-1 diabetes, from ages six to eighteen. Sanofi collaborated with its German partner, Haselmeier GmbH, to manufacture JuniorSTAR.

Based on a simple principle, the JuniorSTAR is an insulin pen offering dosing flexibility with the use of half-unit reusable amounts of Lantus (insulin glargine), Apidra (insulin glulisine) or Insuman (recombinant human insulin). Sanofi focused on designing a pen that is very light, has a large display, features a single-step dial back and can deliver between 1 to 30 units per injection.

As a matter of fact, the JuniorSTAR pen has already met its market with positive feedback: a survey conducted by Sanofi found that an average of 80-90 percent of patients and nurses recommend it for its appealing features: easy to carry, easy to read, easy to use!

Everyone deserves high-quality care while learning to manage their diabetes, for the best chance in life,” comments Pierre Chancel, Senior Vice President, Global Diabetes, Sanofi. We could not have said it better!